Serum level of maternal human immunodeficiency virus (HIV) RNA, infant mortality, and vertical transmission of HIV in Zimbabwe

被引:30
作者
Katzenstein, DA
Mbizvo, M
Zijenah, L
Gittens, T
Munjoma, M
Hill, D
Madzime, S
Maldonado, Y
机构
[1] Stanford Univ, Med Ctr, Ctr AIDS Res, Div Infect Dis & Geog Med,Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[3] Univ Zimbabwe, Dept Immunol, Harare, Zimbabwe
[4] Univ Zimbabwe, Dept Obstet & Gynecol, Harare, Zimbabwe
关键词
D O I
10.1086/314767
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Maternal human immunodeficiency virus (HIV) RNA load, vertical transmission of subtype C HIV, and infant mortality were examined in 251 HIV-seropositive women and their infants in Zimbabwe. Demographic characteristics, health and medical histories, serum HIV RNA loads, and CD4(+) lymphocyte counts for mothers were examined by logistic regression analysis to determine significant risk factors and their odds ratios for transmission and infant mortality. Tenfold (1 log(10)) incremental increases in maternal HIV RNA were associated with a 1.9-fold increase (95% confidence interval [CI], 1.2-2.9) in transmission and a 2.1-fold increase (95% CI, 1.3-3.5) in infant mortality (P <.01). Maternal CD4 cell counts and demographic and medical characteristics were not significant predictors of transmission, However, maternal CD4 cell counts below the median (400/mm(3)) were significantly associated with infant mortality (P=.035, Fisher's exact test). The maternal level of serum HIV is an important determinant of vertical transmission and infant mortality in subtype C infection In Zimbabwe.
引用
收藏
页码:1382 / 1387
页数:6
相关论文
共 40 条
[1]  
ALEXIO LF, 1997, J PEDIATR, V130, P906
[2]   INCUBATION PERIODS FOR PEDIATRIC AIDS PATIENTS [J].
AUGER, I ;
THOMAS, P ;
DEGRUTTOLA, V ;
MORSE, D ;
MOORE, D ;
WILLIAMS, R ;
TRUMAN, B ;
LAWRENCE, CE .
NATURE, 1988, 336 (6199) :575-577
[3]   Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission [J].
Biggar, RJ ;
Miotti, PG ;
Taha, TE ;
Mtimavalye, L ;
Broadhead, R ;
Justesen, A ;
Yellin, F ;
Liomba, G ;
Miley, W ;
Waters, D ;
Chiphangwi, D ;
Goedert, JJ .
LANCET, 1996, 347 (9016) :1647-1650
[4]   Vertical HIV-1 transmission correlates with a high maternal viral load at delivery [J].
Coll, O ;
Hernandez, M ;
Boucher, CAB ;
Fortuny, C ;
deTejada, BM ;
Canet, Y ;
Caragol, I ;
Tijnagel, J ;
Bertran, JM ;
Espanol, T .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 14 (01) :26-30
[5]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[6]  
Coste J, 1996, J MED VIROL, V50, P293, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt
[7]  
293::AID-JMV3&gt
[8]  
3.0.CO
[9]  
2-3
[10]   6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso:: a double-blind placebo-controlled multicentre trial [J].
Dabis, F ;
Msellati, P ;
Meda, N ;
Welffens-Ekra, C ;
You, B ;
Manigart, O ;
Leroy, V ;
Simonon, A ;
Cartoux, M ;
Combe, P ;
Ouangré, A ;
Ramon, R ;
Ky-Zerbo, O ;
Montcho, C ;
Salamon, R ;
Rouzioux, C ;
Van de Perre, P ;
Mandelbrot, L .
LANCET, 1999, 353 (9155) :786-792